跳至主要内容
临床试验/NCT07058935
NCT07058935招募中不适用

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

National Heart Centre Singapore8 个研究点 分布在 6 个国家目标入组 150 人开始时间: 2025年3月17日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
8
主要终点
All-cause mortality

研究概览

简要总结

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)

排除标准

  • Active endocarditis
  • Any other conditions which investigator deems unsuitable for participation.

结局指标

主要结局

All-cause mortality

时间窗: From date of procedure to 10 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

The Asia-Pacific Mitral & Tricuspid... | 临床试验